XUNGENE THERAPEUTICS
Latest round
- Angel
Last raised
- Sep 2023
Total raised
- Undisclosed
Investors
- 4
About XUNGENE THERAPEUTICS
Founded in 2023 and based in Beijing, China, XUNGENE THERAPEUTICS is a biopharmaceutical company that focuses on the R&D of RNA small molecule drugs. It has independent intellectual property rights of RNA structure detection and artificial intelligence technology. The company was co-founded by Prof. Qiangfeng Zhang from the School of Life Sciences at Tsinghua University and Prof. Yangming Wang from the School of Future Technology at Peking University. XUNGENE THERAPEUTICS's product is RNA small molecule drugs. The products can be used in the treatment of rare diseases and cancers. The company has built three world-leading technology platforms which are RNA structure data platform, targeted RNA small molecule high-throughput screening platform, and RNA-small molecule interaction artificial intelligence computing platform.
Who invested in XUNGENE THERAPEUTICS
4 investors across 1 round
See all investors in XUNGENE THERAPEUTICS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Sep 18, 2023
Amount
Undisclosed
Investors
Questions about XUNGENE THERAPEUTICS
Who invested in XUNGENE THERAPEUTICS?
XUNGENE THERAPEUTICS has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has XUNGENE THERAPEUTICS raised?
XUNGENE THERAPEUTICS has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did XUNGENE THERAPEUTICS last raise money?
XUNGENE THERAPEUTICS's most recent round on record is a Angel, in Sep 2023.
What does XUNGENE THERAPEUTICS do?
Founded in 2023 and based in Beijing, China, XUNGENE THERAPEUTICS is a biopharmaceutical company that focuses on the R&D of RNA small molecule drugs.
Where is XUNGENE THERAPEUTICS headquartered?
XUNGENE THERAPEUTICS is headquartered in Beijing, China.
Which VCs invest in companies like XUNGENE THERAPEUTICS?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare it companies at XUNGENE THERAPEUTICS's stage. Their profiles are linked below.
VCs backing healthcare it startups at Angel
Raising like XUNGENE THERAPEUTICS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.